Francesca M. Quaglia
Verona, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Refining risk stratification for mantle cell lymphoma: integrating novel combination treatments and personalized approaches.
Journal: Expert review of hematology
Published: August 05, 2026
Pirtobrutinib in Richter syndrome: Outcomes from the named patient programme in Italy.
Journal: British journal of haematology
Published: May 15, 2026
Ibrutinib Dose Adjustment Does Not Impair Treatment Outcome in Mantle Cell Lymphoma: An Italian Real-Life Multicenter Experience. Results From the REDOT_MCL Study.
Journal: Hematological oncology
Published: November 17, 2025
Multicenter real-life evaluation of the Post-CAR prognostic index for patients with large B-cell lymphoma after CAR-T failure.
Journal: Journal of hematology & oncology
Published: September 28, 2025
B-cell receptor signaling and microenvironment crosstalk in mantle cell lymphoma.
Journal: Cell communication and signaling : CCS
Published: August 01, 2025
The role of time to first progression and fitness status in elderly patients with mantle cell lymphoma: Results from the ELDERLY MANTLE-FIRST study.
Journal: HemaSphere
Published: May 13, 2025
Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study.
Journal: The Lancet. Haematology
Published: April 28, 2025
Richter transformation in diffuse large B-cell lymphoma in patients with chronic lymphocytic leukemia receiving ibrutinib: risk factors and outcomes.
Journal: Leukemia
Published: January 09, 2025
Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantation.
Journal: British journal of haematology
Published: October 08, 2024
Last Updated: 09/26/2026